Bayesian Capital Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-39,716
| Closed | -$641K | – | 949 |
|
|
2023
Q3 | $641K | Buy |
+39,716
| New | +$641K | 0.07% | 313 |
|
|
2023
Q2 | – | Sell |
-11,200
| Closed | -$674K | – | 984 |
|
|
2023
Q1 | $674K | Buy |
+11,200
| New | +$674K | 0.08% | 314 |
|
|
2022
Q3 | – | Sell |
-4,850
| Closed | -$337K | – | 927 |
|
|
2022
Q2 | $337K | Buy |
+4,850
| New | +$337K | 0.06% | 436 |
|
|
2021
Q2 | – | Sell |
-2,894
| Closed | -$383K | – | 577 |
|
|
2021
Q1 | $383K | Buy |
2,894
+435
| +18% | +$57.6K | 0.09% | 293 |
|
|
2020
Q4 | $426K | Buy |
+2,459
| New | +$426K | 0.11% | 239 |
|
|
2020
Q1 | – | Sell |
-2,700
| Closed | -$228K | – | 918 |
|
|
2019
Q4 | $228K | Buy |
+2,700
| New | +$228K | 0.04% | 501 |
|
|
2017
Q1 | – | Sell |
-10,189
| Closed | -$80K | – | 617 |
|
|
2016
Q4 | $80K | Buy |
+10,189
| New | +$80K | 0.02% | 567 |
|